No Data
Express News | PMV : Oppenheimer Raises to Outperform From Perform
Oppenheimer Upgrades PMV Pharmaceuticals(PMVP.US) to Buy Rating, Announces Target Price $6
TD Cowen Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating
Optimistic Buy Rating for PMV Pharmaceuticals Driven by Strategic Clinical Trials and Strong Financial Position
Express News | PMV Pharmaceuticals: Cash, Cash Equivalents, & Marketable Securities of $197.9 Mln as Sept 30, Providing Expected Cash Runway to End of 2026
PMV Pharmaceuticals | 10-Q: Quarterly report
No Data
No Data